Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes

Cell Cycle

Volumn 14, Issue 14, 2015, Pages 2219-2221

  Kurzrock, Razelle ^a   Giles, Francis J ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Robert H Lurie Comprehensive Cancer Center of Northwestern University ^*  (United States)

Author keywords

Cancer; Genomics; Precision oncology; Targeted therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; BREAST METASTASIS; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GENETICS; CANCER PATIENT; CANCER THERAPY; CLINICAL RESEARCH; GENE STRUCTURE; HUMAN; METASTASIS; NEXT GENERATION SEQUENCING; PERSONALIZED MEDICINE; PRECISION ONCOLOGY; CANCER STAGING; CLASSIFICATION; DNA SEQUENCE; GENOMICS; HIGH THROUGHPUT SEQUENCING; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PATHOLOGY;

GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASM STAGING; NEOPLASMS; PRECISION MEDICINE; SEQUENCE ANALYSIS, DNA;

EID: 84940181679     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1041695     Document Type: Article

References (6)

1. Wheler JJ, Parker BA, Lee JJ, Atkins JT, Janku F, Tsimberidou AM, Zinner R, Subbiah V, Fu S, Schwab R, et al. Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms. Oncotarget 2014; 5 (9): 2349-54; PMID: 24811890.
2. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, et al. Mutational landscape and significance across 12 major cancer types. Nature 2013; 502 (7471): 333-9; PMID: 24132290; http://dx. doi. org/10. 1038/nature12634.
3. Wheler JJ, Lee JJ, Kurzrock R. Unique Molecular Landscapes in Cancer: Implications for Individualized, Curated Drug Combinations. Cancer Res 2014; 74 (24): 7181-4; [Epub ahead of print]; PMID: 25326492; http://dx. doi. org/10. 1158/0008-5472. CAN-14-2329.
4. Shaw AT, Kim DW, Mehra R, Tan DS, Felip E, Chow LQ, Camidge DR, Vansteenkiste J, Sharma S, De Pas T, et al. Ceritinib in ALK-rearranged non-small-cell lung cancer. N Engl J Med 2014; 370: 1189-97; PMID: 24670165; http://dx. doi. org/10. 1056/NEJMoa 1311107.
5. Charles L, Sawyers MD. Chronic myeloid leukemia. N Engl J Med 1999; 340: 1330-40; PMID: 10219069; http://dx. doi. org/10. 1056/NEJM199904293401706.
6. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74; PMID: 21376230; http://dx. doi. org/10. 1016/j. cell. 2011. 02. 013.